Recent Statin Use and 1-Year Incidence of Exudative Age-Related Macular Degeneration

American Journal of Ophthalmology

Volumn 149, Issue 6, 2010, Pages

  Fong, Donald S ^a   Contreras, Richard ^a  

^a KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; ATORVASTATIN; COLESTIPOL; COLESTYRAMINE; EZETIMIBE; FENOFIBRATE; GEMFIBROZIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; PRAVASTATIN; SIMVASTATIN;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; EXUDATIVE RETINA MACULA AGE RELATED DEGENERATION; EYE EXAMINATION; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; STROKE; TREATMENT DURATION; UNITED STATES;

EID: 77952672357     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2009.12.037     Document Type: Article

References (28)

1. Tan J.S., Wang J.J., Liew G., Rochtchina E., and Mitchell P. Age-related macular degeneration and mortality from cardiovascular disease or stroke. Br J Ophthalmol 92 (2008) 509-512
2. Sun C., Klein R., and Wong T.Y. Age-related macular degeneration and risk of coronary heart disease and stroke: the Cardiovascular Health Study. Ophthalmology 116 (2009) 1913-1919
3. Wong T.Y., and Rogers S.L. Statins and age-related macular degeneration: time for a randomized controlled trial?. Am J Ophthalmol 144 (2007) 117-119
4. Wong T.Y., Klein R., Sun C., et al. Age-related macular degeneration and risk for stroke. Ann Intern Med 145 (2006) 98-106
5. Alexander S.L., Linde-Zwirble W.T., Werther W., et al. Annual rates of arterial thromboembolic events in medicare neovascular age-related macular degeneration patients. Ophthalmology 114 (2007) 2174-2178
6. Nguyen-Khoa B.A., Goehring Jr. E.L., Werther W., et al. Hospitalized cardiovascular diseases in neovascular age-related macular degeneration. Arch Ophthalmol 126 (2008) 1280-1286
7. Haddad S., Chen C.A., Santangelo S.L., and Seddon J.M. The genetics of age-related macular degeneration: a review of progress to date. Surv Ophthalmol 51 (2006) 316-363
8. Seddon JM, Gensler G, Milton RC, et al. Association between C-reactive protein and age-related macular degeneration. JAMA 1004;291:704-710.
9. Seddon J.M., George S., Rosner B., and Rifai N. Progression of age-related macular degeneration: prospective assessment of c-reactive protein, interleukin 6, and other cardiovascular biomarkers. Arch Ophthalmol 123 (2005) 774-782
10. Friedman E. The role of atherosclerotic process in the pathogenesis of age-related macular degeneration. Am J Ophthalmol 130 (2000) 658-662
11. Hall N.F., Gale C.R., Syddall H., Phillips D.I.W., and Martyn C.N. Risk of macular degeneration in users of statins: cross-sectional study. BMJ 323 (2001) 375-376
12. McGwin G., Owsley C., Curcio C.A., and Crain R.J. The association between statin use and age-related maculopathy. Br J Ophthalmol 87 (2003) 1121-1125
13. McCarty C.A., Mukesh B.N., Guymer R.H., Baird P.N., and Taylor H.R. Cholesterol-lowering medications reduce the risk of age-related maculopathy progression. Med J Aust 175 (2001) 340
14. Schwartz D.M., Bhatt H.R., McCulloch C.E., and Duncan J.L. Statin and aspirin therapy are associated with decreased rates of choroidal neovascularization among patients with age-related macular degeneration. Am J Ophthalmol 137 (2004) 615-624
15. Klein R., Klein B.E.K., Tomany S.C., Danforth L.G., and Cruickshanks K.J. Relation of statin use to the 5-year incidence and progression of age-related maculopathy. Arch Ophthalmol 121 (2003) 1151-1155
16. Van Leewen R., Tomany S.C., Wang J.J., et al. Is medication use associated with the incidence of early age-related maculopathy?. Pooled findings from 3 continents. Ophthalmol 111 (2004) 1169-1175
17. Tan J.S., Mitchell P., Rochtchina E., and Wang J.J. Statins and the long-term risk of incident age-related macular degeneration: The Blue Mountain Study. Am J Ophthalmol 143 (2007) 685-687
18. Klein R., Knudtson M.D., and Klein B.E. Statin use and the five-year incidence and progression of age-related macular degeneration. Am J Ophthalmol 144 (2007) 1-6
19. Maguire M.G., Ying Jr. F., McCannel C.A., et al. Statin use and the incidence of advanced age-related macular degeneration in the complications of age-related macular degeneration prevention trial. Ophthalmology 116 (2009) 2381-2385
20. The Long-term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 339 (1998) 1349-1357
21. Byington R.P., Davis B.R., Plehn J.F., et al. Reduction of stroke events with pravastatin: the Prospective Pravastatin Pooling (PPP) Project. Circulation 103 (2001) 387-392
22. The Long-term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 339 (1998) 1349-1357
23. Byington R.P., Davis B.R., Plehn J.F., et al. Reduction of stroke events with pravastatin: the Prospective Pravastatin Pooling (PPP) Project. Circulation 103 (2001) 387-392
24. Dithmar S., Curcio C.A., Le N.A., Brown S., and Grossniklaus H.E. Ultrastructural changes in Bruch's membrane of apolipoprotein E-deficient mice. Invest Ophthalmol Vis Sci 41 (2000) 2035-2042
25. Kureishi Y., Luo Z., Shiojima I., et al. The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholeterolemic animals. Nat Medicine 6 (2000) 965-966
26. Klein R., Klein B.E.K., Tomany S.C., Danforth L.G., and Cruickshanks K.J. Relation of statin use to the 5-year incidence and progression of age-related maculopathy. Arch Ophthalmol 121 (2003) 1151-1155
27. Van Leewen R., Tomany S.C., Wang J.J., et al. Is medication use associated with the incidence of early age-related maculopathy?. Pooled findings from 3 continents. Ophthalmol 111 (2004) 1169-1175
28. Tan J.S., Mitchell P., Rochtchina E., and Wang J.J. Statins and the long-term risk of incident age-related macular degeneration: The Blue Mountain Study. Am J Ophthalmol 143 (2007) 685-687